OUTLOOK THERAPEUTICS, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
OUTLOOK THERAPEUTICS, INC. (OTLK) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$1.35 million for the 6-month period ending 2018-03-31, per its 10-Q filed 2018-05-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-15
- OUTLOOK THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was -$275.19K.
- OUTLOOK THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was -$1.08M.
- OUTLOOK THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$23.98K.
- OUTLOOK THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$76.23K.
- OUTLOOK THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$292.09K.
- OUTLOOK THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$1.10M.
- OUTLOOK THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$8.80M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2018-03-31 | -$275.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-15 | -$1.35M 10-Q · filed 2018-05-15 | -$1.37M derived: sum of 3 quarters · filed 2018-05-15 | -$1.45M derived: sum of 4 quarters · filed 2018-05-15 |
| 2017-12-31 | -$1.08M 10-Q · filed 2018-02-14 | -$1.10M derived: sum of 2 quarters · filed 2018-02-14 | -$1.18M derived: sum of 3 quarters · filed 2018-02-14 | -$1.22M derived: sum of 4 quarters · filed 2018-05-15 |
| 2017-09-30 | -$23.98K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-29 | -$100.21K derived: sum of 2 quarters · filed 2017-12-29 | -$143.72K derived: sum of 3 quarters · filed 2018-05-15 | -$292.09K 10-K · filed 2017-12-29 |
| 2017-06-30 | -$76.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-14 | -$119.74K derived: sum of 2 quarters · filed 2018-05-15 | -$268.11K 10-Q · filed 2017-08-14 | -$596.52K derived: sum of 4 quarters · filed 2018-05-15 |
| 2017-03-31 | -$43.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-15 | -$191.88K 10-Q · filed 2018-05-15 | -$520.29K derived: sum of 3 quarters · filed 2018-05-15 | -$972.76K derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | -$148.36K 10-Q · filed 2018-02-14 | -$476.77K derived: sum of 2 quarters · filed 2018-02-14 | -$929.25K derived: sum of 3 quarters · filed 2018-02-14 | -$882.30K derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-09-30 | -$328.41K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-29 | -$780.89K derived: sum of 2 quarters · filed 2017-12-29 | -$733.94K derived: sum of 3 quarters · filed 2017-12-29 | -$1.10M 10-K · filed 2017-12-29 |
| 2016-06-30 | -$452.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-14 | -$405.53K derived: sum of 2 quarters · filed 2017-08-14 | -$769.77K 10-Q · filed 2017-08-14 | -$4.06M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | $46.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-15 | -$317.29K 10-Q · filed 2017-05-15 | -$3.61M derived: sum of 3 quarters · filed 2017-05-15 | -$7.10M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | -$364.24K 10-Q · filed 2017-02-14 | -$3.66M derived: sum of 2 quarters · filed 2017-02-14 | -$7.15M derived: sum of 3 quarters · filed 2017-02-14 | |
| 2015-09-30 | -$3.29M derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-29 | -$6.78M derived: sum of 2 quarters · filed 2016-12-29 | -$8.80M 10-K · filed 2016-12-29 | |
| 2015-06-30 | -$3.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-15 | -$5.51M 10-Q · filed 2016-08-15 | ||
| 2015-03-31 | -$2.02M 10-Q · filed 2016-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |